Suppr超能文献

即时检验以改善血糖控制。

Point of care testing to improve glycemic control.

作者信息

Rust George, Gailor Morna, Daniels Elvan, McMillan-Persaud Barbara, Strothers Harry, Mayberry Robert

机构信息

National Center for Primary Care, Morehouse School of Medicine, Atlanta, Georgia, USA.

出版信息

Int J Health Care Qual Assur. 2008;21(3):325-35. doi: 10.1108/09526860810868256.

Abstract

PURPOSE

The purpose of this paper is to pilot-test the feasibility and impact of protocol-driven point-of-care HbAlc testing on levels of glycemic control and on rates of diabetic regimen intensification in an urban community health center serving low-income patients.

DESIGN/METHODOLOGY/APPROACH: The paper suggests a primary care process re-design, using point of care finger-stick HbA1c testing under a standing order protocol that provided test results to the provider at patient visit.

FINDINGS

The paper finds that the protocol was well received by both nurses and physicians. HbA1c testing rates increased from 73.6 percent to 86.8 percent (p = 0.40, n = 106). For the 69 patients who had both pre- and post-intervention results, HbAlc levels decreased significantly from 8.55 to 7.84 (p = 0.004, n = 69). At baseline, the health center as a system was relatively ineffective in responding to elevated HbA1c levels. An opportunity to intensify, i.e. a face-to-face visit with lab results available, occurred for only 68.6 percent of elevated HbAlc levels before the intervention, vs. 100 percent post-intervention (p < 0.001). Only 28.6 percent of patients with HbAlc levels >8.0 had their regimens intensified in the pre-intervention phase, compared with 53.8 percent in the post-intervention phase (p = 0.03).

RESEARCH LIMITATIONS/IMPLICATIONS: This was a pilot-study in one urban health center. Larger group-randomized controlled trials are needed.

PRACTICAL IMPLICATIONS

The health center's performance as a system, improved significantly as a way of intensifying diabetic regimens thereby achieving improved glycemic control.

ORIGINALITY/VALUE: This intervention is feasible, replicable and scalable and does not rely on changing physician behaviors to improve primary care diabetic outcomes.

摘要

目的

本文旨在对协议驱动的即时糖化血红蛋白(HbAlc)检测在一家为低收入患者服务的城市社区卫生中心的可行性和影响进行试点测试,该检测针对血糖控制水平和糖尿病治疗方案强化率。

设计/方法/途径:本文建议重新设计初级保健流程,采用即时护理手指采血糖化血红蛋白检测,依据长期医嘱协议,在患者就诊时向医生提供检测结果。

研究结果

本文发现该协议受到护士和医生的一致好评。糖化血红蛋白检测率从73.6%提高到86.8%(p = 0.40,n = 106)。对于69例有干预前后结果的患者,糖化血红蛋白水平从8.55显著降至7.84(p = 0.004,n = 69)。基线时,作为一个系统的健康中心在应对升高的糖化血红蛋白水平方面相对无效。干预前,只有68.6%的糖化血红蛋白水平升高的患者有机会强化治疗,即进行面对面就诊并获得实验室结果,而干预后这一比例为100%(p < 0.001)。干预前,糖化血红蛋白水平>8.0的患者中只有28.6%的治疗方案得到强化,而干预后这一比例为53.8%(p = 0.03)。

研究局限性/启示:这是在一家城市卫生中心进行的试点研究。需要进行更大规模的群组随机对照试验。

实际意义

作为一个系统,健康中心的表现显著改善,以此强化糖尿病治疗方案,从而实现更好的血糖控制。

原创性/价值:这种干预措施可行、可复制且可扩展,不依赖改变医生行为来改善初级保健糖尿病治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验